For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies.

TitleDifferential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies.
Publication TypeJournal Article
Year of Publication2010
AuthorsLee G, Xiang Z, Brannagan TH, Chin RL, Latov N
JournalJ Neurol Sci
Volume290
Issue1-2
Pagination115-22
Date Published2010 Mar 15
ISSN1878-5883
KeywordsAdaptor Proteins, Signal Transducing, Adolescent, Adult, Biological Markers, Biopsy, DNA-Binding Proteins, Female, Gene Expression Profiling, Gene Expression Regulation, Genetic Predisposition to Disease, Humans, Inflammation, Inflammation Mediators, Male, Middle Aged, Nerve Tissue Proteins, Nuclear Proteins, Peripheral Nerves, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Receptors, Purinergic P2, Receptors, Purinergic P2Y1, Reverse Transcriptase Polymerase Chain Reaction, RNA, Messenger, Sensory Receptor Cells, Skin, Vesicular Transport Proteins, Young Adult
Abstract

Gene expression analysis previously identified molecular markers that are up-regulated in sural nerve biopsies from patients with chronic inflammatory demyelinating polyneuropathy (CIDP). To determine whether the same or additional genes are also up-regulated in skin, we applied gene microarray profiling and quantitative real-time PCR (qPCR) analysis to skin punch biopsies from patients with CIDP and controls. Five genes, allograft inflammatory factor 1 (AIF-1), lymphatic hyaluronan receptor (LYVE-1/XLKD1), FYN binding protein (FYB), P2RY1 (purinergic receptor P2Y, G-protein-coupled, 1), and MLLT3 (myeloid/lymphoid or mixed-lineage leukemia translocated to, 3), all associated with immune cells or inflammatory processes, were elevated in punch skin biopsies from patients with CIDP as compared to normal subjects or patients with Charcot-Marie-Tooth Type 1 (CMT1). The average fold change of the 5 genes over normal expression, as determined by qPCR, was significantly elevated in skin biopsies from patients with CIDP in comparison to CMT1 or diabetic neuropathy, and similar to that seen in Lyme disease. The findings indicate the presence of inflammatory changes in the skin of patients with CIDP.

DOI10.1016/j.jns.2009.10.006
Alternate JournalJ. Neurol. Sci.
PubMed ID19922956

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587